DK1545605T3 - Komposition til vaccination - Google Patents

Komposition til vaccination

Info

Publication number
DK1545605T3
DK1545605T3 DK03750381.0T DK03750381T DK1545605T3 DK 1545605 T3 DK1545605 T3 DK 1545605T3 DK 03750381 T DK03750381 T DK 03750381T DK 1545605 T3 DK1545605 T3 DK 1545605T3
Authority
DK
Denmark
Prior art keywords
compositions
immunogen
methods
vaccination
occlusion vehicle
Prior art date
Application number
DK03750381.0T
Other languages
English (en)
Inventor
Peter Borman Samuelsen
Nikolai Soren Kikrby
Original Assignee
Nordic Vaccine As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK200201473A external-priority patent/DK200201473A/da
Application filed by Nordic Vaccine As filed Critical Nordic Vaccine As
Application granted granted Critical
Publication of DK1545605T3 publication Critical patent/DK1545605T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
DK03750381.0T 2002-10-02 2003-10-02 Komposition til vaccination DK1545605T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41510202P 2002-10-02 2002-10-02
DK200201473A DK200201473A (da) 2002-10-02 2002-10-02 Vaccinepræparater
PCT/DK2003/000654 WO2004030696A2 (en) 2002-10-02 2003-10-02 Composition for vaccination

Publications (1)

Publication Number Publication Date
DK1545605T3 true DK1545605T3 (da) 2010-04-12

Family

ID=32070988

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03750381.0T DK1545605T3 (da) 2002-10-02 2003-10-02 Komposition til vaccination

Country Status (9)

Country Link
EP (1) EP1545605B8 (da)
JP (1) JP2006503072A (da)
AT (1) ATE449612T1 (da)
AU (1) AU2003269839B2 (da)
CA (1) CA2500911A1 (da)
DE (1) DE60330257D1 (da)
DK (1) DK1545605T3 (da)
NZ (1) NZ539008A (da)
WO (1) WO2004030696A2 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7635488B2 (en) 2001-03-13 2009-12-22 Dbv Technologies Patches and uses thereof
FR2822049B1 (fr) 2001-03-13 2003-08-01 Dbv Medica 1 Patch destine notamment a depister l'etat de sensibilisation d'un sujet a un allergene, procede de fabrication et utilisation
US7887842B2 (en) 2003-02-07 2011-02-15 Teikoku Pharma Usa, Inc. Methods of administering a dermatological agent to a subject
SE0300795D0 (sv) 2003-03-24 2003-03-24 Isconova Ab Composition comprising iscom particles and live micro-organisms
WO2006078213A1 (en) 2005-01-20 2006-07-27 Isconova Ab Vaccine composition comprisinga fibronectin binding protein or a fibronectin binding peptide
JP5054546B2 (ja) * 2006-02-07 2012-10-24 エヌエーアイ株式会社 新規ワクチン担体
WO2008105504A1 (ja) * 2007-03-01 2008-09-04 Cosmed Pharmaceutical Co., Ltd. 経皮免疫製剤、その製造方法及びそれを用いた経皮免疫方法
US20100113348A1 (en) * 2007-03-01 2010-05-06 Fumio Kamiyama Percutaneously absorbable preparation, process for production thereof and method for percutaneous absorption
FR2921562B1 (fr) * 2007-10-01 2012-06-15 Dbv Tech Dispositif adhesif pour application cutanee
FR2924350B1 (fr) * 2007-12-03 2010-08-13 Dbv Tech Procede et compositions pour la vaccination par voie cutanee
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
WO2009106085A1 (en) * 2008-02-28 2009-09-03 Nordic Vaccine A/S Vaccine compositions comprising saccharide antigens
US20110159035A1 (en) 2008-08-01 2011-06-30 Masahiro Goto S/o type transdermal immunizing agent
WO2011128430A1 (en) * 2010-04-16 2011-10-20 Dbv Technologies Method of vaccination
JP5263349B2 (ja) * 2011-08-08 2013-08-14 生化学工業株式会社 生理活性分子含有架橋ヘパリンゲル組成物
ES2673957T5 (es) 2011-10-03 2021-12-15 Croda Int Plc Nanopartículas, procedimiento para la preparación y utilización de las mismas como portadoras de moléculas anfipáticas o hidrofóbicas en el campo de la medicina, incluyendo el tratamiento del cáncer, y compuestos de tipo alimentario
WO2014163558A1 (en) 2013-04-01 2014-10-09 Moreinx Ab Nanoparticles, composed of sterol and saponin from quillaja saponaria molina process for preparation and use thereof as carrier for amphipatic of hydrphobic molecules in fields of medicine including cancer treatment and food related compounds
KR102484824B1 (ko) * 2020-09-03 2023-01-05 주식회사 중앙백신연구소 동물용 미끼백신 및 이의 제조방법
KR102621024B1 (ko) * 2023-09-12 2024-01-05 (주)진코스텍 심미감 및 피부 흡수력이 개선된 하이드로겔 패치

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9002314A (nl) * 1990-10-23 1992-05-18 Nederlanden Staat Immunogene complexen, in het bijzonder iscoms.
SE502569C2 (sv) * 1991-05-31 1995-11-13 British Tech Group Användning av en immunologiskt inert matris av en sterol och saponiner som kan bilda sfäriska nanopartiklar med snäv storleksfördelning som läkemedelsbärare, partiklar, komposition samt kit
US5306504A (en) * 1992-12-09 1994-04-26 Paper Manufactures Company Skin adhesive hydrogel, its preparation and uses
AUPO517897A0 (en) * 1997-02-19 1997-04-11 Csl Limited Chelating immunostimulating complexes
AUPO732997A0 (en) * 1997-06-12 1997-07-03 Csl Limited Ganglioside immunostimulating complexes and uses thereof
US5993852A (en) * 1997-08-29 1999-11-30 Pharmaderm Laboratories Ltd. Biphasic lipid vesicle composition for transdermal administration of an immunogen
US6013258A (en) * 1997-10-09 2000-01-11 Zycos Inc. Immunogenic peptides from the HPV E7 protein
AU3311599A (en) * 1998-02-25 1999-09-15 Iomai Corporation Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin
GB9817052D0 (en) 1998-08-05 1998-09-30 Smithkline Beecham Biolog Vaccine
PT1031346E (pt) * 1999-01-27 2002-09-30 Idea Ag Vacinacao nao invasiva atraves da pele
WO2000061184A2 (en) * 1999-04-08 2000-10-19 Glenn Gregory M Dry formulation for transcutaneous immunization
GB9920167D0 (en) * 1999-08-25 1999-10-27 Avery Dennison Corp Pressure sensitive adhesive compositions
CA2445486A1 (en) * 2001-03-19 2002-09-26 Iomai Corporation Patch for transcutaneous immunization
JP2004528321A (ja) * 2001-04-04 2004-09-16 ノルディック ワクチン テクノロジー アクティーゼルスカブ ステロールおよびサポニンを含むポリヌクレオチド結合複合体

Also Published As

Publication number Publication date
DE60330257D1 (de) 2010-01-07
WO2004030696A2 (en) 2004-04-15
CA2500911A1 (en) 2004-04-15
WO2004030696A3 (en) 2004-05-06
JP2006503072A (ja) 2006-01-26
WO2004030696A8 (en) 2004-06-10
NZ539008A (en) 2006-10-27
AU2003269839A1 (en) 2004-04-23
EP1545605B1 (en) 2009-11-25
EP1545605B8 (en) 2010-05-26
EP1545605A2 (en) 2005-06-29
ATE449612T1 (de) 2009-12-15
AU2003269839B2 (en) 2006-07-27

Similar Documents

Publication Publication Date Title
DK1545605T3 (da) Komposition til vaccination
WO2006068663A3 (en) Vaccine compositions for treating coronavirus infection
ATE426412T1 (de) Adjuvante influenza-vakzine
NO20061912L (no) Vaksinesammensetninger omfattende et interleukin 18 og saponin adjuvant system
WO2005116270A3 (en) Influenza virus vaccine composition and method of use
ATE330967T1 (de) An her2 bindende peptidverbindungen
MA29406B1 (fr) Vaccin toxoide alpha de c. perfringens
EE05633B1 (et) Muundatud vaktsiiniaviirus Ankara (MVA), sellega nakatatud peremeesrakk ning seda sisaldav farmatseutiline kompositsioon, MVA valmistamine ja raviotstarbeline kasutamine
WO2008133663A3 (en) Codon modified immunogenic compositions and methods of use
ATE391491T1 (de) Konditionierungszusammensetzungen mit hydrophobisch modifizierten vernetzten kationischen verdickungspolymeren
ATE350010T1 (de) Zusammensetzung zur topischen anwendung
PT1409692E (pt) Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina
ATE269113T1 (de) Sprühfähige wundversorgungszusammensetzung
ATE402211T1 (de) Verfahren zur herstellung von farblosen, lagerstabilen biuretgruppenhaltigen polyisocyanaten
WO2006023598A3 (en) Prostate-specific antigen-derived mhc class ii-restricted peptides and their use in vaccines to treat or prevent prostate cancer
WO2005013918A3 (en) Compositions, methods and kits relating to poxvirus subunit vaccines
WO2008057158A3 (en) Novel neutralizing immunogen (nimiv) of rhinovirus and its use for vaccine applications
BR0207528A (pt) Anticorpo, composição farmacêutica, e, usos de uma quantidade efetiva de um agente, de uma quantidade terapeuticamente efetiva de um anticorpo para il-22, de uma quantidade imunogênica do antìgeno e uma quantidade aumentadora de imunogenicidade de il-22 em combinação, de uma quantidade efetiva do anticorpo ou fragmento do mesmo e de uma quantidade suficiente de anticorpo ou fragmento ligado a antìgeno do mesmo
ATE473756T1 (de) Pharmazeutische zusammensetzung zur behandlung oder prävention von ovarialkrebs
UA107177C2 (uk) Імуногенна композиція цвс2 та спосіб приготування такої композиції
ATE349531T1 (de) Isolierung und charakterisierung des csa-operons (etec-cs4 pili) und verfahren zu dessen anwendung
SE9903534D0 (sv) Vaccin
ATE476987T1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
ATE476197T1 (de) Rekombinante vakzine gegen infektion mit dem japanischen enzephalitis-virus äjevü und verfahren davon